The hardware and bandwidth for this mirror is donated by dogado GmbH, the Webhosting and Full Service-Cloud Provider. Check out our Wordpress Tutorial.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]dogado.de.
An implementation of representation-dependent gene level operations for genetic algorithms with genes which represent permutations: initialization of genes, mutation and crossover. The crossover operation provided is position-based crossover (Syswerda, G., Chap. 21 in Davis, L. (1991, ISBN:0-442-00173-8). For mutation, several variants are included: Order-based mutation (Syswerda, G., Chap. 21 in Davis, L. (1991, ISBN:0-442-00173-8), randomized Lin-Kernighan heuristics (Croes, G. A. (1958) <doi:10.1287/opre.6.6.791> and Lin, S. and Kernighan. B. W. (1973) <doi:10.1287/opre.21.2.498>), and randomized greedy operators. A random mix operator for mutation selects a mutation variant randomly.
Version: | 1.0.0.0 |
Imports: | xegaSelectGene |
Suggests: | testthat (≥ 3.0.0) |
Published: | 2024-02-05 |
DOI: | 10.32614/CRAN.package.xegaPermGene |
Author: | Andreas Geyer-Schulz [aut, cre] |
Maintainer: | Andreas Geyer-Schulz <Andreas.Geyer-Schulz at kit.edu> |
License: | MIT + file LICENSE |
URL: | <https://github.com/ageyerschulz/xegaPermGene> |
NeedsCompilation: | no |
Materials: | README |
CRAN checks: | xegaPermGene results |
Reference manual: | xegaPermGene.pdf |
Package source: | xegaPermGene_1.0.0.0.tar.gz |
Windows binaries: | r-devel: xegaPermGene_1.0.0.0.zip, r-release: xegaPermGene_1.0.0.0.zip, r-oldrel: xegaPermGene_1.0.0.0.zip |
macOS binaries: | r-release (arm64): xegaPermGene_1.0.0.0.tgz, r-oldrel (arm64): xegaPermGene_1.0.0.0.tgz, r-release (x86_64): xegaPermGene_1.0.0.0.tgz, r-oldrel (x86_64): xegaPermGene_1.0.0.0.tgz |
Reverse imports: | xega |
Please use the canonical form https://CRAN.R-project.org/package=xegaPermGene to link to this page.
These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.
Health stats visible at Monitor.